Cuba vs Netherlands: Prevalence of current tobacco use, males
Prevalence of current tobacco use, males over time
- Cuba
- Netherlands
How they compare
Cuba currently reports 23.6% against 23.0% in Netherlands, a difference of 0.6%.
Across all 9 years both countries report, Cuba has been ahead every year.
Cuba ranks 102nd and Netherlands ranks 104th of 166 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.1% | 34.5% | 10.6% | Cuba |
| 2010s | 34.1% | 29.0% | 5.1% | Cuba |
| 2020s | 24.9% | 23.8% | 1.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, males, Cuba or Netherlands?
- Cuba, at 23.6% against 23.0% in Netherlands as of 2024.
- What is the difference in prevalence of current tobacco use, males between Cuba and Netherlands?
- 0.6%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Netherlands?
- 9 years are reported by both, from 2000 to 2024.
- How do Cuba and Netherlands rank globally for prevalence of current tobacco use, males?
- Cuba ranks 102nd and Netherlands ranks 104th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.